Company news
Pyxis Oncology, Inc. news in 2023
Pyxis Oncology, Inc.'s news releases, calls and decks from 2023, newest first.
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
November 27, 2023
Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update
November 6, 2023
Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023
September 26, 2023
Pyxis Oncology to Participate in Two Upcoming Investment Conferences
August 30, 2023
Pyxis Oncology Successfully Completes Acquisition of Apexigen
August 22, 2023
Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update
August 10, 2023
Pyxis Oncology to Present at BTIG Virtual Biotechnology Conference
July 31, 2023
Pyxis Oncology Advances PYX-106 and PYX-201 Clinical Programs
May 29, 2023
Pyxis Oncology to Acquire Apexigen
May 23, 2023
Pyxis Oncology Reports Financial Results for the First Quarter 2023 and Provides Corporate Update
May 10, 2023
Pyxis Oncology Reports Financial Results for the Fiscal Year Ended December 31, 2022, and Provides Corporate Update
March 21, 2023
Pyxis Oncology Announces Dosing of First Subject in Phase 1 Trial of PYX-201, a Novel ADC for Solid Tumors
March 15, 2023
Pyxis Oncology to Participate in the Virtual 2023 SVB Securities Global Biopharma Conference
February 12, 2023